Retrospective Analysis of Posaconazole Suspension Dosing Strategies in a Pediatric Oncology Population: Single-Center Experience

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e149-e151. doi: 10.1093/jpids/pix058.

Abstract

Limited data on optimal posaconazole dosing strategies for pediatric patients exist. In this study, we found that the median initial dose in patients who achieved a posaconazole plasma concentration of 0.7 μg/mL was 22.8 mg/kg per day whereas the median initial dose in those who did not reach the target concentration was 15.8 mg/kg per day; this result suggests that higher initial doses might be warranted.

Keywords: oncology; pediatrics; posaconazole.

MeSH terms

  • Adolescent
  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / blood
  • Antifungal Agents / therapeutic use
  • Child
  • Child, Preschool
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Neoplasms / complications*
  • Retrospective Studies
  • Suspensions
  • Triazoles / administration & dosage*
  • Triazoles / blood
  • Triazoles / therapeutic use

Substances

  • Antifungal Agents
  • Suspensions
  • Triazoles
  • posaconazole